Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in REPL — Replimune Group, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$857,426
+$437,105 QoQ
Shares Held
77,455
+41.0% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 199 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. REPL ranks #147 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in REPL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $857,426 77,455
2026-03-31 $420,321 54,944
2025-12-31 $524,335 53,944
2025-09-30 $2,260,784 539,567
2025-06-30 $4,951,634 533,007
2025-03-31 $5,496,084 563,701
2024-12-31 $6,800,502 561,561
2024-09-30 $5,870,614 535,640
2024-06-30 $4,753,224 528,136
2024-03-31 $4,265,115 522,046
2023-12-31 $1,161,476 137,779
2023-09-30 $320,093 18,708
2023-06-30 $3,144,777 135,434
2023-03-31 $2,675,948 151,526
2022-12-31 $3,846,243 141,406
2022-09-30 $2,355,472 136,391
2022-06-30 $2,355,692 134,765
2022-03-31 $2,332,490 137,367
2021-12-31 $534,194 19,712
2021-09-30 $2,643,827 89,198
2021-06-30 $3,380,497 87,988
2021-03-31 $3,094,140 101,414
2020-12-31 $9,418,776 246,888
2020-09-30 $259,711 11,282
2020-06-30 $217,461 8,751
2020-03-31 $44,346 4,448